Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Bionxt Solutions Inc (OP: XPHYF )

N/A UNCHANGED
Last Price Updated: 3:44 PM EST, Dec 21, 2022 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Bionxt Solutions Inc

< Previous 1 2 3 Next >
XPhyto Completes Strategic Acquisition of 3a-diagnostics GmbH
- The acquisition positions XPhyto to be a leading Biosensor producer integrating thin film technology with 3a-diagnostics biosensor technology - The acquisition of 3a, a German-based rapid... 
From XPhyto Therapeutics Corp.
Via AccessWire
Topics Cannabis Intellectual Property
Exposures COVID-19 Cannabis Intellectual Property
XPhyto Therapeutics Announces Stock Option Grants
THIS NEWS RELEASE IS NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES FOR DISSEMINATION IN THE UNITED STATES VANCOUVER, BC / ACCESSWIRE / December 3, 2021 / XPhyto Therapeutics Corp.... 
From XPhyto Therapeutics Corp.
Via AccessWire
XPhyto Therapeutics Closes Private Placements for Gross Proceeds of $7,000,0000
NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES VANCOUVER, BC / ACCESSWIRE / November 26, 2021 / XPhyto Therapeutics Corp. ("XPhyto" or the "Company")... 
From XPhyto Therapeutics Corp.
Via AccessWire
InvestorNewsBreaks – XPhyto Therapeutics Corp. (CSE: XPHY) (OTCQB: XPHYF) (FSE: 4XT) Appoints New CFO
Via Investor Brand Network
XPhyto Announces CFO Appointment
VANCOUVER, BC and UTTENWEILER, GERMANY / ACCESSWIRE / November 19, 2021 / XPhyto Therapeutics Corp. (CSE:XPHY)(OTCQB:XPHYF)(FSE:4XT) ("XPhyto" or the "Company") is pleased to announce the appointment... 
From XPhyto Therapeutics Corp.
Via AccessWire
Topics Cannabis
Exposures Cannabis
XPhyto Therapeutics Corp. (CSE: XPHY) (OTCQB: XPHYF) Featured in Coverage of Investor Summit Group’s Q4 Virtual Event
Via Investor Brand Network
XPhyto Announces Managing Director Appointment, Financing and 3a-diagnostics Development
NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES VANCOUVER, BC and UTTENWEILER, GERMANY / ACCESSWIRE / November 3, 2021 / XPhyto Therapeutics Corp.... 
From XPhyto Therapeutics Corp.
Via AccessWire
Topics Cannabis
Exposures Cannabis
InvestorNewsBreaks – XPhyto Therapeutics Corp. (CSE: XPHY) (OTCQB: XPHYF) (FSE: 4XT) Shares Drug-Development Update
Via Investor Brand Network
XPhyto Reports Development Update for its Drug Delivery Business
- Rotigotine transdermal skin patch optimization and pivotal study planning underway - Rotigotine patch manufacturing, sales and marketing in preparation - Cannabinoid oral dissolvable film (ODF)... 
From XPhyto Therapeutics Corp.
Via AccessWire
Topics Cannabis
Exposures Cannabis
InvestorNewsBreaks – XPhyto Therapeutics Corp. (CSE: XPHY) (OTCQB: XPHYF) (FSE: 4XT) Extends Agreements with Partners
Via Investor Brand Network
Xphyto Announces Engagement of Consultants for Marketing and Promotional Activities
VANCOUVER, BC / ACCESSWIRE / October 8, 2021 / XPhyto Therapeutics Corp. (CSE:XPHY)(OTCQB:XPHYF)(FSE:4XT) ("XPhyto" or the"Company") announces it has entered into extensions to investor relations... 
From XPhyto Therapeutics Corp.
Via AccessWire
COVID Tests, THC Patches, Psychedelics: Xphyto Therapeutics Does it All
Image by Shameer Pk from Pixabay From 25-minute COVID-19 lab tests to psychedelic medicine that is poised to address mental health conditions like PTSD, XPhyto Therapeutics (... 
Via Benzinga
Exposures COVID-19
XPhyto Reports Successful Market Launch and Growing Demand for its 25-minute COVID-19 PCR Test COVID-ID Lab
VANCOUVER, BC and FRANKFURT, GERMANY / ACCESSWIRE / September 8, 2021 / XPhyto Therapeutics Corp. (CSE:XPHY) (OTCQB:XPHYF) (FSE:4XT) ("XPhyto" or the "Company") is pleased to announce the successful... 
From XPhyto Therapeutics Corp.
Via AccessWire
Topics Cannabis
Exposures COVID-19 Cannabis
XPhyto Launches First Commercial Biosensor for Oral Disease
- Biosensor test dissolves on the tongue and turns bitter indicating the presence of oral inflammation after five minutes - Easy and simple at-home self-checks improve oral health and indicate... 
From XPhyto Therapeutics Corp.
Via AccessWire
Topics Cannabis
Exposures Cannabis
420 with CNW — Senators, Feds Discuss Cannabis Legalization During Drug Overdose Hearing
Via CannabisNewsWire
Topics Cannabis Death
Exposures Cannabis Death
XPhyto’s Acquisition Target, 3a-Diagnostics, Reports Breakthrough Identification of COVID-19 Biosensor Candidates
- First saliva activated biosensor molecules identified to diagnose COVID-19 infection using XPhyto's oral dissolvable delivery platform - Biosensor candidates are ready for optimization and... 
From XPhyto Therapeutics Corp.
Via AccessWire
Topics Cannabis
Exposures COVID-19 Cannabis
420 with CNW — Three Tips for New Medical Cannabis Patients
Via CannabisNewsWire
Topics Cannabis
Exposures Cannabis
XPhyto Signs Transformative Acquisition Agreement With 3a-Diagnostics, to Enter Hi-Tech Biosensor Market and Expand Its Diagnostic Product Portfolio
- The acquisition creates significant commercial development and manufacturing opportunities for XPhyto as well as cost synergies and improved margins on its diagnostic products. - The acquisition... 
From XPhyto Therapeutics Corp.
Via AccessWire
Topics Cannabis Intellectual Property
Exposures COVID-19 Cannabis Intellectual Property
420 with CNW — Federal Economic Committee Recommends Marijuana Reclassification as Industry Continues to Grow
Via CannabisNewsWire
Topics Cannabis
Exposures Cannabis
420 with CNW — Study Finds That Marijuana Possesses Strain-Specific Effect on Driving Performance
Via CannabisNewsWire
Topics Cannabis
Exposures Cannabis
XPhyto Announces Advertising Agreement with Agora Internet Relations Corp.
VANCOUVER, BC / ACCESSWIRE / July 2, 2021 / XPhyto Therapeutics Corp. (CSE:XPHY)(OTCQB:XPHYF)(FSE:4XT) ("XPhyto" or the "Company") announces that pursuant to its advertising agreement with AGORA... 
From XPhyto Therapeutics Corp.
Via AccessWire
Topics Cannabis
Exposures Cannabis
XPhyto Supplies 10 Test Centers in Berlin with 25-minute COVID-19 PCR Test
- XPhyto signs master supply agreement with operator of 10 COVID-19 test centers - The test will be offered to customers as a rapid PCR test with sample processing on site - Commercial operations... 
From XPhyto Therapeutics Corp.
Via AccessWire
Topics Cannabis
Exposures COVID-19 Cannabis
420 with CNW — California Earmarks $100M to Support Licensed Cannabis Firms During Pandemic
Via CannabisNewsWire
Topics Cannabis Law Enforcement
Exposures Cannabis Legal
420 with CNW — Medical Marijuana Activists in Pennsylvania See Workers’ Comp. Decision as a Win
Via CannabisNewsWire
Topics Cannabis
Exposures Cannabis
420 with CNW — Congressional Bill Could Enable Researchers to Study Cannabis from Dispensaries
Via CannabisNewsWire
Topics Cannabis
Exposures Cannabis
420 with CNW — Study Finds That CBD May Improve Overall Wellness
Via CannabisNewsWire
Topics Cannabis
Exposures Cannabis
XPhyto Provides Progress Report on Mescaline Program for Psychedelic Therapies
- Research and development lab set up, preliminary mescaline synthesis complete - Modified synthesis process developed, mescaline batches manufactured - Development of analytical methods and... 
From XPhyto Therapeutics Corp.
Via AccessWire
Topics Cannabis Intellectual Property
Exposures Cannabis Intellectual Property
Benzinga Cannabis Capital Conference - June 4 Agenda
The premier gathering of cannabis entrepreneurs and investors in North America returns for an all-day virtual event on June 3-4. 
Via Benzinga
Topics Cannabis
Exposures Cannabis
420 with CNW — Cannabis Prohibition Costs $53 Billion Annually in the US
Via CannabisNewsWire
Topics Cannabis Economy
Exposures COVID-19 Cannabis Economy
420 with CNW — How the State of New York Plans to Tax Marijuana
Via CannabisNewsWire
Topics Cannabis
Exposures Cannabis
< Previous 1 2 3 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.